Electrophoresis Reagents Market Size (2024 - 2029)

The electrophoresis reagents market is anticipated to experience growth due to several key factors, including increased funding for genomic and proteomic research, a rising prevalence of chronic diseases, and advancements in technology. The market's expansion is further supported by the demand for electrophoresis techniques in developing therapies and diagnostics, particularly highlighted during the COVID-19 pandemic. Despite these growth drivers, challenges such as time-consuming processes and the presence of alternative methods may hinder the market's potential.

Market Size of Electrophoresis Reagents Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Electrophoresis Reagents Market Summary
Study Period 2021 - 2029
Base Year For Estimation 2023
CAGR 5.11 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Low

Major Players

Electrophoresis Reagents Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Electrophoresis Reagents Market Analysis

The Electrophoresis Reagents Market is expected to register a CAGR of 5.11% during the forecast period.

Globally, the outbreak of COVID-19 was an incomparable public health emergency that affected the healthcare industry. The pandemic has had a notable impact on the market growth as electrophoresis techniques were used to develop effective therapies to separate DNA, RNA, or protein molecules based on their size for effective therapies against COVID-19. For instance, as per the National Clinical Trial (NCT) Registry updated in July 2022, Elsan conducted a clinical trial to assess serum inflammation profiles by protein electrophoresis on patients hospitalized for infection due to the SARS-CoV-2 virus. Such increasing research and development activities in developing effective therapies were expected to increase the demand for electrophoresis reagents during the COVID-19 pandemic. In addition, gel electrophoresis with other diagnostic technology was used to detect COVID-19. According to the study published in NCBI in November 2021, applying conventional PCR in conjunction with gel-electrophoresis for testing analysis is a possible approach for making SARS-CoV-2 diagnostics available worldwide. As a result, during the COVID-19 pandemic, the need for coronavirus disease diagnosis increased. This trend is expected to continue during the forecast period owing to the emergence of multiple variants, propelling the market growth.

The major factors driving the electrophoresis reagents market include the increasing funding for genomic and proteomic research; the rising prevalence of chronic diseases; increasing collaborations between industry and academia; and technological developments. According to the World Health Organization factsheet published in February 2022, in 2021, an estimated 1.9 million new cancer cases were diagnosed in the United States. The report also mentioned that each year, approximately 400,000 children develop cancer globally. Cervical cancer is the most common in 23 countries, such as Eswatini, India, South Africa, Latin America, and others. The most common cancers are breast, lung, colon and rectum, and prostate cancers.

Additionally, for instance, the British Heart Foundation (BHF) data published in January 2022 reported that in 2021, the most common heart conditions affected globally were coronary (ischemic) heart disease (global prevalence estimated at 200 million), peripheral arterial (vascular) disease (110 million), stroke (100 million) and atrial fibrillation (60 million). The report also mentioned that the prevalence of heart and circulatory diseases in North America was 46 million, in Europe 99 million, in Africa 58 million, in South America 32 million, in Asia and Australia 310 million. As the prevalence of chronic diseases increases, researchers continue to focus on providing prospective treatment options through research and development, which raises the need for gel electrophoresis, and electrophoresis reagents, consequently promoting the market's growth.

Additionally, technological advancement in electrophoresis instruments further propels the market's growth. For instance, in September 2021, a novel capillary electrophoresis system, BioPhase8800, was introduced by Sciex Company for biological characterization during biopharmaceutical therapy. The new device analyses eight samples simultaneously and is a multi-capillary system for Capillary Electrophoresis Sodium Dodecyl Sulfate (CE-SDS).

Therefore, factors like increasing funding for genomic and proteomic research, the rising prevalence of chronic diseases, and technological developments are expected to promote the growth of the electrophoresis reagents market over the forecast period. However, time-consuming operations and the availability of other alternatives may restrain the market's growth over the forecast period.

Electrophoresis Reagents Industry Segmentation

As per the scope of the report, electrophoresis is a technique used to separate DNA, RNA, and proteins using an electrical current based on the molecular weight or fragment size. The electrophoresis reagents used in the electrophoresis technique are known as electrophoresis reagents. This technology is widely used in the fields of medical diagnostics, life sciences, and clinical research. 

The Electrophoresis Reagents Market is segmented by Product (Gels (Agarose Gels, Polyacrylamide Gels, and Starch Gels), Dyes (Ethidium Bromide (ETBR) Dyes, Bromophenol Blue, Sybr Dyes, and Other Dyes), Buffers (Tris/Acetate/EDTA, Tris/Borate/EDTA, and Other Buffers), and Other Products), Technique (Gel Electrophoresis and Capillary Electrophoresis), End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Laboratories, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Product
Gels
Agarose Gels
Polyacrylamide Gels
Starch Gels
Dyes
Ethidium Bromide (ETBR) Dyes
Bromophenol Blue
Sybr Dyes
Other Dyes
Buffers
Tris/Acetate/EDTA
Tris/Borate/EDTA
Other Buffers
Other Products
By Technique
Gel Electrophoresis
Capillary Electrophoresis
By End User
Academic and Research Institutions
Pharmaceutical and Biotechnology Companies
Laboratories
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Electrophoresis Reagents Market Size Summary

The Electrophoresis Reagents Market is poised for steady growth, driven by several key factors. The market is experiencing a surge in demand due to increased funding for genomic and proteomic research, the rising prevalence of chronic diseases, and technological advancements in electrophoresis instruments. The COVID-19 pandemic significantly impacted the market, as electrophoresis techniques were crucial in developing therapies and diagnostics for the virus. This trend is expected to continue with the emergence of new variants, further propelling market growth. The market is characterized by a moderate level of fragmentation and competition, with major players employing strategies such as partnerships, product launches, and mergers to strengthen their market positions.

North America is anticipated to hold a significant share of the market, supported by a robust pipeline of genomic research projects, a high prevalence of chronic diseases, and substantial research and development expenditure. The region benefits from the presence of major industry players and continuous technological advancements. The demand for effective therapeutics and diagnostics, driven by the high incidence of cancer and infectious diseases, is a key factor contributing to market expansion. The gel electrophoresis segment, in particular, is gaining traction due to its low operational costs and increasing applications in the pharmaceutical and biotechnology sectors. Overall, the market is expected to grow steadily, with ongoing innovations and strategic collaborations playing a pivotal role in its development.

Explore More

Electrophoresis Reagents Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Funding for Genomic and Proteomic Research

      2. 1.2.2 Rising Prevalence of Chronic Diseases

      3. 1.2.3 Technological Developments

    3. 1.3 Market Restraints

      1. 1.3.1 Time-consuming Operations

      2. 1.3.2 Presence of Alternative Technologies

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Product

      1. 2.1.1 Gels

        1. 2.1.1.1 Agarose Gels

        2. 2.1.1.2 Polyacrylamide Gels

        3. 2.1.1.3 Starch Gels

      2. 2.1.2 Dyes

        1. 2.1.2.1 Ethidium Bromide (ETBR) Dyes

        2. 2.1.2.2 Bromophenol Blue

        3. 2.1.2.3 Sybr Dyes

        4. 2.1.2.4 Other Dyes

      3. 2.1.3 Buffers

        1. 2.1.3.1 Tris/Acetate/EDTA

        2. 2.1.3.2 Tris/Borate/EDTA

        3. 2.1.3.3 Other Buffers

      4. 2.1.4 Other Products

    2. 2.2 By Technique

      1. 2.2.1 Gel Electrophoresis

      2. 2.2.2 Capillary Electrophoresis

    3. 2.3 By End User

      1. 2.3.1 Academic and Research Institutions

      2. 2.3.2 Pharmaceutical and Biotechnology Companies

      3. 2.3.3 Laboratories

      4. 2.3.4 Other End Users

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle-East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle-East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Electrophoresis Reagents Market Size FAQs

The Electrophoresis Reagents Market is projected to register a CAGR of 5.11% during the forecast period (2024-2029)

Agilent Technologies Inc., BioAtlas, Lonza Group AG, Bio-Rad Laboratories Inc. and Qiagen NV are the major companies operating in the Electrophoresis Reagents Market.

Electrophoresis Reagents Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)